Care departed from good and accepted medical practice, jury says; troubled physician finally surrenders his license; delayed diagnosis prompts med-mal suit.
Two new cancer drugs were recommended for approval, and one had its marketing authorization withdrawn at the October meeting of the European Medicines Agency s advisory panel.
A lawsuit alleged that a patient died because the surgical oncologist did not make it clear to the treatment team that the tumor had not been completely resected.